Demystifying Bio-Techne: Insights From 4 Analyst Reviews
Demystifying Bio-Techne: Insights From 4 Analyst Reviews
揭开生物科技的神秘面纱：来自4条分析师评论的见解
4 analysts have shared their evaluations of Bio-Techne (NASDAQ:TECH) during the recent three months, expressing a mix of bullish and bearish perspectives.
近三个月来，有4位分析师分享了他们对Bio-Techne（纳斯达克股票代码：TECH）的评估，他们表达了看涨和看跌的观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $85.75, with a high estimate of $95.00 and a low estimate of $81.00. This current average reflects an increase of 8.54% from the previous average price target of $79.00.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为85.75美元，最高估计为95.00美元，低估值为81.00美元。目前的平均价格比之前的平均目标价79.00美元增长了8.54％。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
A comprehensive examination of how financial experts perceive...
对金融专家如何看...
登录免费看全文
登录/注册